The accused stock swindler who famously jacked up the price of a lifesaving drug 5,000 percent will finally face a judge, on the very day LGBT people celebrate marriage equality.
Derided for raising the price of a medication used by some with HIV, the former drug executive refused to answer questions and later insulted the committee.
The pharma CEO, now hit with securities fraud charges, is a potent symbol of corporate greed. Now we need to learn from Shkreli's bad example and reform his industry, writes Kit Williamson.
A report says Martin Shkreli's Turing Pharmaceuticals will 'roll back' the price of a lifesaving treatment for people living with HIV — but only for hospitals.
The pharmaceutical CEO, who recently hiked the cost of an AIDS drug, had hoped to parlay his contribution into a private meeting with the presidential candidate.
